Case study
AI-powered platform automating clinical site evaluation for faster, compliant trial startups
The solution leverages AI agents to automate sequential clinical site evaluation, with validated handoffs between feasibility and pre-activation stages so that only qualified sites advance to contracting and activation.
- Industry
- Healthcare & Life Sciences
- Category
- Artificial Intelligence
- Engagement
- AI-Driven Site Feasibility & Qualification Platform
- Users
- Sponsors, CROs & Clinical Research Associates (CRAs)
Results at a glance
- 0140% faster clinical trial launches
Automated, protocol-aligned site evaluation and structured CRA qualification shortened the path from feasibility to trial activation.
- 0230% reduction in site selection cycle time
AI-assisted scoring, shortlisting, and sequential agent handoffs reduced the time needed to identify and qualify suitable sites.
- 03Higher Selection Accuracy
AI-driven automation improves accuracy and consistency in site evaluation, reducing the risk of subjective or error-prone decisions.
01The client
Customer
The client operates in the Clinical Research and Life Sciences space, supporting sponsor- and CRO-oriented clinical trial operations.
Trial timelines were routinely delayed by poor site selection, missing documents, staffing gaps, and regulatory issues, resulting in delayed FPFV, higher costs, protocol deviations, and heavy manual coordination overhead.
Site evaluation relied on traditional, manual workflows (manual reviews, email questionnaires, and subjective scoring) rather than a standardized, data-driven process.
02Challenge
Business Challenge
As trial volumes grew, the client's clinical operations team faced a set of operational and compliance challenges that made site selection slow, inconsistent, and difficult to audit:
- 01Inconsistent Site Scoring
Site evaluations relied on subjective, manual reviews rather than standardized, protocol-aligned criteria.
- 02Limited Historical Insight
Feasibility decisions lacked access to historical site performance data, making comparisons across sites unreliable.
- 03Manual Document Verification
Verifying site documentation by hand slowed reviews and left the process with poor audit readiness.
- 04Fragmented CRA Qualification
CRA-led site qualification processes were fragmented, lacking digital standardization or integration into activation pipelines.
- 05Undetected Early Risks
Inefficient feasibility evaluations produced slow, inconsistent decisions and let operational and compliance risks go undetected until later stages.
- 06Delayed Trial Startups
Poor site selection, missing documents, staffing gaps, and regulatory issues delayed FPFV, increased costs, and caused protocol deviations.
03Solution
Solution
The solution leverages AI agents to automate sequential clinical site evaluation, with validated handoffs between feasibility and pre-activation stages so that only qualified sites advance to contracting and activation.
Assesses site suitability against protocol requirements and historical performance data to generate AI-assisted site shortlisting.
Verifies operational readiness, confirming documents, staffing, and compliance checks are complete before a site can proceed.
Validated handoffs between feasibility and pre-activation stages eliminate subjective site selection and detect risks early.
Enforces structured, CRA-led site qualification, digitizing what was previously a manual, fragmented process.
Generates inspection-ready audit trails and secure compliance workflows throughout the evaluation process.
Protocol-driven automation and configurable AI scoring, with mandatory CRA validation built into every decision.
04How we delivered
Implementation
The clinical site evaluation process was implemented as a sequential, agent-driven workflow that moves each site from initial protocol input to an activation-ready decision.
- Step 1Protocol Input
Trial protocol requirements are fed into the platform as the starting point for site evaluation.
- Step 2Feasibility Assessment
The Feasibility Agent performs scraping, scoring, questionnaire processing, and validation to shortlist suitable sites based on protocol requirements and historical data.
- Step 3Pre-Activation Verification
Shortlisted sites move to the Pre-Activation Agent, which handles CRA onboarding, SQV (Site Qualification Visit) checklists, document validation, and scheduling.
- Step 4AI-Driven Qualification
The Pre-Activation Agent applies AI-driven qualification checks, confirming staffing, documentation, and compliance are complete.
- Step 5Activation Readiness
Only sites that pass both stages are marked activation-ready, with a structured, inspection-ready audit trail generated at each step.
05Technology
Technology
- Backend Framework
- FastAPIPython 3.10+
- Workflow Orchestration
- LangGraph for event-drivenagent-based workflow management
- Data Storage
- PostgreSQL
- Automation & Scraping
- Selenium for site data scraping
- Security & Access
- JWT-based Role-Based Access Control (RBAC)
- Deployment
- Docker containers for scalability and maintainability
06Results
The AI-driven site evaluation platform delivered measurable improvements in trial startup speed and site selection efficiency.
- 40% faster clinical trial launches
Automated, protocol-aligned site evaluation and structured CRA qualification shortened the path from feasibility to trial activation.
- 30% reduction in site selection cycle time
AI-assisted scoring, shortlisting, and sequential agent handoffs reduced the time needed to identify and qualify suitable sites.
07Business impact
Beyond faster site evaluation, the platform gives the client a more consistent, audit-ready, and scalable approach to clinical trial startups.
AI-driven automation improves accuracy and consistency in site evaluation, reducing the risk of subjective or error-prone decisions.
Structured workflows and sequential agent handoffs reduce manual errors and keep the client audit- and compliance-ready.
Early detection of operational and regulatory risks helps the client avoid delays and costly site failures before they happen.
Integrating mandatory CRA validation with AI insights lets the client scale automation without losing human oversight.
End-to-end, inspection-ready audit trails strengthen regulatory preparedness and traceability across every site decision.
Reduced site activation failures and improved operational efficiency support more reliable trial startups going forward.
More projects like this
All case studiesFacing a similar challenge?
Tell us what you need. A technical lead will reply within one business day with how we would approach it.
- Reply within one business day
- Free 30-minute call
- NDA before you share data